Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Virologic response to bictegravir/emtricitabine/tenofovir alafenamide in people with advanced HIV-1 disease: A propensity-weighted multicentre cohort study
Tsung-Yu Tsai; Chin-Shiang Tsai; Sung-Hsi Huang; Tzong-Yow Wu; Po-Wei Chiu; Wang-Da Liu; Andrew Po-Liang Chen; Kuan-Yin Lin; Chien-Ching HungShow moreShow less
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan; School of Medicine, College of Medicine, National Yung-Ming Chiao-Tung University, Taipei, TaiwanShow moreShow less
Pharmacovigilance signals and regional burden of antibiotic-associated Clostridioides difficile infection: A pharmacovigilance study and Global Burden of Disease Study 2023
Dain Y. Kim; Hyunjeong Kim; Hyunyi Yoo; Hyoin Shin; Hyunju Yon; Taelim Choi; Junmo Moon; Hyunjee Kim; José Francisco López-Gil; Masoud Rahmati; Selin Woo; Jaeyu Park; Dong Keon YonShow moreShow less
Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, Korea University College of Medicine, Seoul, South Korea; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea; School of Medicine, Universidad Espíritu Santo, Samborondón, Ecuador; Vicerrectoría de Investigación y Postgrado, Universidad de Los Lagos, Osorno, Chile; Health Service Research and Quality of Life Center (CEReSS), Aix-Marseille University, Marseille, France; Clinical Research Unit, Delegation a la Recherche Clinique et a l’Innovation du GHT, Centre Hospitalier Intercommunal Toulon La Seyne sur-Mer, Toulon, France; Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South KoreaShow moreShow less
Genomic epidemiology and resistance determinants of Pseudomonas aeruginosa in bronchiectasis across China: A multicentre study
Linlin Xu; Qing Chen; Aikuang Ma; Kang Xu; Lianyan Xie; Jingyong Sun; Xiaoli WangShow moreShow less
Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
Ecological antagonism constrains receptor-diverse phage cocktail efficacy against multidrug-resistant Enterobacter hormaechei
Bai-Ling Zhang; Ming-Yu Jiang; Xiu-Zhen Chen; Xiao-Qi Yang; Wei-Xiao Wang; Guang-Ming Zhang; Shuang-Lin Gu; Le-Le Xiong; Ying Chen; Zi-Xuan Cui; Tian-Hao Mao; Cai-Yun Zhang; Shi-Wei Wang; Chun-Mei Hu; Wei Lin; Wei ChenShow moreShow less
Department of Blood Transfusion, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China; Clinical Research Center, the Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, China; Department of Tuberculosis, the Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Northwest University, Xi’an 710069, China; The key Laboratory of Hepatology of Nanjing, the Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003, China; School of Medicine, Nanjing University of Chinese Medicine, Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing 210023, ChinaShow moreShow less
Daptomycin or linezolid versus vancomycin for the treatment of vancomycin-susceptible Enterococcus faecium bloodstream infections
Samantha Poloni; Timothée Klopfenstein; Adrien Biguenet; Mathieu Blot; Damien Bichard; Lina Ben Sari; Isabelle Patry; Catherine Chirouze; Kevin Bouiller; Anne-Sophie BrunelShow moreShow less
Service de Maladies Infectieuses, CHU Besançon, Besançon, France; Service de Maladies Infectieuses, Hôpital Nord Franche-Comté, Trevenans, France; Unité de Recherche Clinique, Hôpital Nord Franche-Comté, Trevenans, France; Université de Franche-Comté, UMR-CNRS 6249, Chrono-Environnement, Service d’Hygiène Hospitalière, Besançon, France; Service de Maladies Infectieuses, CHU Dijon, Dijon, France; Pôle Pharmacie, CHU Besançon, Besançon, France; Service de Bactériologie Médicale, CHU Besançon, Besançon, France; Université de Franche-Comté, UMR-CNRS 6249, Chrono-Environnement, Service de Maladies Infectieuses, Besançon, FranceShow moreShow less
FIRL potentiates antibiotic activity against multidrug-resistant Gram-negative bacteria: Selective BamA–BamD interface perturbation induces functional outer membrane vulnerability
Wenwen Li; Bingjie Ji; Weixuan Wen; Jiale Tuo; Shangxiao Li; Yue Wu; Siying Qin; Hongtong Chen; Jin Luo; Jinghai Zhang; Xinyi Yang; Yongshan ZhaoShow moreShow less
School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, China; Postdoctoral Research Station of Clinical Medicine, Hebei Medical University, Shijiazhuang, Hebei, China; School of Medical Devices, Shenyang Pharmaceutical University, Benxi, Liaoning, China; Beijing Key Laboratory of Antimicrobial Agents/Laboratory of Pharmacology/State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Division for Medicinal Microorganism-Related Strains, CAMS Collection Center of Pathogenic Microorganisms, Beijing, China; Army Infantry Academy, Nanchang, ChinaShow moreShow less
FAQ
How long does International Journal of Antimicrobial Agents take to review a manuscript?
As of 2026-11-13, CrushSCI has 15 complete review records for International Journal of Antimicrobial Agents. The fastest paper went from submission to acceptance in 53 days (Early prediction of carbapenem resistance phenotype in ICU-acquired Acinetobacter baumannii infection before susceptibility reporting: A temporally validated study, received 2026-06-11, accepted 2026-08-03); the slowest took 242 days. The average is 136.3 days and the median is 129 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
